Beta-globin mRNA increases rapidly during erythropoietin treatment

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 3, 2003, Pages 239-246

  Hagberg, A ^a   Barbany, G ^a   Landegren, U ^a   Birgegård, Gunnar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaemia; Gene expression; RT PCR; Treatment marker

Indexed keywords

BETA GLOBIN; FERRITIN; HEMOGLOBIN; MESSENGER RNA; NUCLEASE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; DRUG COST; ENZYME ASSAY; FEMALE; GENE EXPRESSION; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETICULOCYTE COUNT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0038806472     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310001339     Document Type: Article

References (12)

1. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987; 316: 73-8.
2. Birgegård G. rHuEpo treatment for the anaemia of multiple myeloma and Non-Hodgin's lymphoma. In: Smyth JF, editor. Rh erythropoietin in cancer supportive treatment. New York: Marcel Dekker, Inc.: 1996. p. 85-98.
3. Henry DH. Clinical application of recombinant erythropoietin in anemic cancer patients. Hematol Oncol Clin North Am 1994; 8: 961-73.
4. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving non-platinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001; 19: 2865-74.
5. Beguin Y. Prediction of response to optimize outcome of treatment with erythropoietin. Semin Oncol 1998; 25: 27-34.
6. Hellstrom-Lindberg E, Negrin R, Stein R, Krantz S, Lindberg G, Vardiman J, Ost A, Greenberg P. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol 1997; 99: 344-51.
7. Gonzales Baron M, Constela M, Montalar J. Epoetin alfa in the treatment of anaemia in cancer patients receiving platinum chemotherapy: response prediction factors. Am J Clin Oncol 1998; ASCO Proc. Abstract 228.
8. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7.
9. Sotiriou C, Powles TJ, Dowsett M, Jazaeri AA, Feldman AL, Assersohn L, Gadisetti C, Libutti SK, Liu ET. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res 2002; 4: R3.
10. Hagberg A, Barbany G, Krook H, Samiotaki M, Landegren U. Expression profiling across many samples via manifold-assisted mRNA processing. Nucleic Acids Res 2000; 28: E54.
11. Heid CA, Stevens, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-94.
12. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996; 6: 995-1001.